Details for New Drug Application (NDA): 022268

✉ Email this page to a colleague

NDA 022268 describes COARTEM, which is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. Additional details are available on the COARTEM profile page.

The generic ingredient in COARTEM is artemether; lumefantrine. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the artemether; lumefantrine profile page.

Summary for 022268

Tradename:	COARTEM
Applicant:	Novartis
Ingredient:	artemether; lumefantrine
Patents:	0

Pharmacology for NDA: 022268

Suppliers and Packaging for NDA: 022268

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
COARTEM	artemether; lumefantrine	TABLET;ORAL	022268	NDA	Novartis Pharmaceuticals Corporation	0078-0568	0078-0568-45	24 TABLET in 1 BOTTLE (0078-0568-45)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	20MG;120MG
Approval Date:	Apr 7, 2009	TE:		RLD:	Yes

Expired US Patents for NDA 022268

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Novartis	COARTEM	artemether; lumefantrine	TABLET;ORAL	022268-001	Apr 7, 2009	5,677,331	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.